United States · Funded startup

Who invested in Senex Biotechnology

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 31 Oct 2026

$600Kraised across 2 rounds since 2011, from 2 sources

$200KDebt$400KDebt
Latest round
Debt, $400KAug 2013
Step-upi
2×
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20122013
$200KDebt$400KDebt
First round
Debt, $200K
May 2011
Biggest round
$400K
Debt · Aug 2013
Between rounds
2.3 years
from the last two

The rounds

  1. Aug 2013
    Debt$400K

    No investor was named in the report.

    Reported by sec.govSEC filing: $400K sold, first sale Jul 2013

  2. May 2011
    Debt$200K

    No investor was named in the report.

    Reported by sec.govSEC filing: $200K sold, first sale Apr 2011

Also claim to have backed them

This firm lists Senex Biotechnology as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Illinois VenturesGovernmentPer its own site

Quick answers about Senex Biotechnology

How much has Senex Biotechnology raised?

Senex Biotechnology has raised $600K across 2 rounds since 2011.

When did Senex Biotechnology last raise?

Senex Biotechnology's most recent round was a Debt of $400K in Aug 2013.

What was Senex Biotechnology's biggest round?

Its most recent round, $400K in Aug 2013, is also its largest on record.

What stage is Senex Biotechnology at?

Senex Biotechnology's latest named round is a Debt, in Aug 2013.

Where is Senex Biotechnology based?

Senex Biotechnology is based in the United States.

Companies like Senex Biotechnology

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.